Filter Results:
(524)
Show Results For
- All HBS Web
(524)
- People (2)
- News (136)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
Show Results For
- All HBS Web
(524)
- People (2)
- News (136)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
- Web
Overview - MBA
students’ existing biotech and life sciences knowledge and equips them with the latest business and scientific insights. Hear from Program Advisors on the impact of this program and the power of the Harvard View Details
- January 2009 (Revised July 2009)
- Case
Targanta Therapeutics: Hitting a Moving Target
By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
- 15 Dec 2009
- First Look
First Look: Dec. 15, 2009
http://cb.hbsp.harvard.edu/cb/product/510037-PDF-ENG Tengion: Bringing Regenerative Medicine to Life Elie Ofek and Polly Ross RibattHarvard Business School Case 510-031 Tengion is a young biotech company that is at the frontier of... View Details
Keywords: Martha Lagace
- Web
Entrepreneurship & Innovation - MBA
into new ventures. Pagliuca Harvard Life Lab The Pagliuca Harvard Life Lab is a wet laboratory with co-working space for early-stage, high-potential biotech and life science start-ups founded by Harvard students, alumni, faculty, and... View Details
- 15 Sep 2010
- Working Paper Summaries
From Bench to Board: Gender Differences in University Scientists’ Participation in Commercial Science
- 15 Oct 2013
- First Look
First Look: October 15
science to consumers. It found it increasingly necessary to direct more of its resources towards marketing, including a major investment in Jennifer Aniston as its celebrity spokesperson. Were they becoming less of a biotech company and... View Details
Keywords: Sean Silverthorne
- 15 May 2007
- First Look
First Look: May 15, 2007
Working PapersI'll Have the Ice Cream Soon and the Vegetables Later: Decreasing Impatience over Time in Online Grocery Orders Authors:Todd Rogers, Katherine L. Milkman, and Max H. Bazerman Abstract How do decisions for the near future differ from decisions for the... View Details
Keywords: Martha Lagace
- March 2023
- Case
Moderna
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19.... View Details
- December 2008 (Revised January 2011)
- Case
Arcadia Biosciences: Seeds of Change
By: Arthur A. Daemmrich, Forest L. Reinhardt and Mary Louise Shelman
Arcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September 2008. The company... View Details
Keywords: Business Startups; Entrepreneurship; Growth and Development Strategy; Environmental Sustainability; Science-Based Business; Climate Change; Agriculture and Agribusiness Industry; Biotechnology Industry; China; India; California
Daemmrich, Arthur A., Forest L. Reinhardt, and Mary Louise Shelman. "Arcadia Biosciences: Seeds of Change." Harvard Business School Case 709-019, December 2008. (Revised January 2011.)
- 23 Jul 2020
- News
The Long Game of Coronavirus Research
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Financial Services Industry; Public Administration Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- Web
Faculty & Advisors - MBA
of AI-enabled health and longevity for all. Paul Clancy MBA, Columbia University; BS, Babson College Paul has worked in the biotech industry for the last twenty-three years and spent fourteen years in the consumer products industry. He... View Details
- 22 Apr 2016
- HBS Seminar
Dr. Milt McColl, MD, Gauss Surgical, CEO
- Web
Live from Klarman Hall - Alumni
Diversity and Inclusion Officer). 2022 Spring Reunions—June 10-11, 2022 Video Recording Building an AI-First Biotech Company Speakers: Stéphane Bancel , CEO, Moderna Therapeutics Karim Lakhani , Dorothy and Michael Hintze Professor of... View Details
- October 2001 (Revised March 2002)
- Case
Perlegen Sciences
By: Linda A. Hill and Nicole Tempest
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,... View Details
Keywords: Innovation Leadership; Groups and Teams; Management Teams; Problems and Challenges; Business Startups; Genetics; Talent and Talent Management; Innovation Strategy; Biotechnology Industry
Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
- Web
Answers to Your Top Questions about Financial Aid at HBS - MBA
Government Health Care / BioTech Manufacturing Private Equity Real Estate Retail Social Enterprise Technology Venture Capital Audiences Audiences FirstGen+ College Diverse Perspectives International LGBTQ+ Military Socioeconomic Inclusion... View Details
- Web
1.3 Academic Calendar - MBA
General Policies 5. Technology, Copyright, & Publishing Policies 6. Important Contact Information Date Event August 1, 2024 2024 – 2025 RC Academic Year Begins for MS/MBA Engineering & Biotech Joint Degree Programs August 20, 2024 2024 –... View Details
- Web
Curriculum - MBA
likely in the life sciences or biotech space. Capstone Overview First Year August Harvard Business School Online CORe Harvard Business School As with all MBA candidates, MS/MBA students take a short test to determine whether they are... View Details
- Web
MBA Voices
Government Health Care / BioTech Manufacturing Private Equity Real Estate Retail Social Enterprise Technology Venture Capital Audiences Audiences FirstGen+ College Diverse Perspectives International LGBTQ+ Military Socioeconomic Inclusion... View Details
- Web
Degrees, Certifications & Alumni Status | About
working at the intersection of science and society, with deep understanding of biotechnology, life sciences, and management. The two-year MS/MBA builds upon students’ existing biotech and life sciences knowledge and equips them with the... View Details